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Post-operative total hip arthroplasty surgical wound infections are associated
with substantial morbidity, mortality, and economic burden. Intra-wound vancomycin
powder application may prevent infections after hip surgery. The objectives of this study
is to answer the question as to whether the application of 2 gram intra-wound vancomycin
powder In patients undergoing total hip arthroplasty, lead to reduced rates of
postoperative surgical site infections or not? From April 2013, 125 patients had consent
prior to their hip surgery. These 125 patients had total hip arthtoplasty by three different
surgeons at Imam Hossein hospital. All patients received either 2 grams of IV Cefazolin
one hour prior to the incision or 1 gram of IV Vancomycin one hour prior to the incision
in patient with a Penicillin allergy. Near the end of the procedure, the wound was
thoroughly irrigated with normal saline. for All patients befor surgical wound closure 2
gram of Vancomycin powder was poured into the wound. Postoperatively, patients
continued on intravenous antibiotics for twenty-four hours. All patients underwent
routine postoperative surgical care including physical therapy, routine radiographs,
and routine managment of pain medications. Laboratory tests include Hb , BUN, Cr and
electrolits were done before surgery and postoperatively after 48 hours and 7 days. All
patients were discharged within the first 3 days after surgery and follow-up at weeks 2
and 4 and one year after surgery was performed. During the course of follow up that has
ranged from one months to one year, sixteen of patients experienced surgical site infection.
10 patients were lost to follow up. No allergic reactions or adverse outcomes were reported
from the use of 2 gram of Vancomycin powder prior to closure. Although intra-wound
application of Vancomycin is known to minimize infections in spinal surgery little
previous studies reported if Vancomycin application will reduce surgical site infection
in hip surgeries. This study demonstrates that intra-wound application of Vancomycin
reduces surgical site infection in total hip arthroplasty without any adverse complications.
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Surgical site infections following hip
surgery are associated with a high morbidity and
mortality and economic burden1-3.
Surgical site infections in hip surgery are
among the most common postoperative
complications. To minimize this risk, several
methods of prophylaxis before, during and after
the surgery are done. Treatment of these infections
often requires long-term antibiotic treatment,
multiple surgical procedures and complex wound
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management. Performance and quality of life of
the patient and family will be impressed. It was
recently shown that the use of intra-wound
vancomycin powder is significantly reducing the
risk of infection without Acute and long-term
associated complications. Vancomycin
administered into the wound prior to wound closure
can reduce the incidence of post-operative surgical
site infection after hip surgery4.
It is Suggested that this method is cost
effective and free of systemic side effects5 but
potential complications include renal toxicity and
life-threatening anaphylaxis6. Recent studies on
intra-wound vancomycin application have reported
different estimates of efficacy. Several observation
studies suggested significant benefits9. The aim
of our study is to evaluate whether or not the intra-
wound vancomycin application can reduce
surgical site infections after hip surgery.
MATERIAL AND METHODS
The informed consent was obtained for
all patients before hip surgery. From April 2013 to
May 2015, 125 patients aged 45 to 91 years
undergoing total hip arthroplasty was performed
by different surgeons at Imam Hossein hospital.
Preoperatively, all patients prepared with
alcohol , followed by 3M(tm) Duraprep(tm) surgical
solution( lodine povacrylex [0/7%available Iodine]
and Isopropyl alcohol, 74% W/W) Patient
preoperative skin prepration. Additionally all
patient received either 2 grams of IV cefazolin one
hour prior to the incision or 1 gram of IV
vancomycin one hour prior to the incision in patient
with a penicillin allergy , which is a standard
systemic prophylaxis in these procedures. No
patient had a known vancomycin allergy.48 patients
were male, 77 were female. Five patients were
revision surgeries. 20 patients needed wire using
because of fracture through broaching. Near the
end of surgery after component insertion the
wound was irrigated with at least 2 liters of normal
saline.
At this point, 2 gram of vancomycin
powder was poured into the wound. Post
operatively patient continued to receive 1 gram of
IV cefazolin every 8 hours for a total of 24 hours.
For the penicillin allergic patient, they received 1
gram of vancomycin every 12 hours for a total of
24 hours.
All patients underwent routine
postoperative surgical care including physical
therapy, routine radiographs and routine
management of pain and Anticoagulant therapy.
Laboratory tests include Hb, BUN, Cr and
electrolytes were done before surgery and
postoperatively after 48 hours and 7 days.
All patients were discharged within the
first 3 days after surgery and follow-up at weeks 2
and 4 and one year after surgery was performed.
RESULTS
The course of follow up ranged from one
month to one year. 10 patients were lost to follow
up.
2 patients died in first 2 months but they
have any sign of surgical site infection or other
complications of intra-wound vancomycin powder.
Creatinine increase occurred in 3 patients, all of
which were created as a result of dehydration and
after sufficient hydration tests returned to initial
normal levels.
No dislocation was reported
A total of 125 patients, including 48 men
and 77 women were divided into two groups.
Case group included 56 patients who had
received intra-wound vancomycin powder at the
end of surgery and the control group consisted of
69 patients who had not received the powder.
2 groups in terms of mean age and gender
distribution did not differ significantly. Statistical
analysis showed a significant difference between
the group receiving intra-wound vancomycin
powder and the control group in terms of the
incidence of postoperative surgical site infections
. The statistical analysis showed that there is
significant difference in average operation time
between patient with and without surgical site
infection Statistical analysis showed that the
incidence of surgical site infection in patients who
smoke are significantly higher than non-smokers
The findings show that in people with diabetes,
the incidence of surgical site infection was
significantly higher than in non-diabetics. The
average age of patients who had surgical site
infection showed no significant difference with
those that were not.
By dividing the patients into two age
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groups above 60 years and below 60 years between
the two groups showed no significant difference
in the incidence of surgical site infection.
debridement, stabilized with external fixation, and
staged Vancomycin-impregnated cancellous bone
grafting. The group found that 100% of the patients
were controlled adequately for infection, and bony
union was achieved in 13 of the 18 patient after an
average of 5.8 months. In the remaining 5 patients,
bone union was achieved with close nailing 4
patients, and plating and bone grafting 1 patient.
They concluded that Vancomycin-
impregnated cancellous bone grafting is an
adequate treatment option for infected tibial
nonunion. These findings are consistent with our
results in terms of intra-wound Vancomycin powder
application will reduce postoperative surgical site
infection.
There are many studies showing the
greater risk of complications and poorer clinical
outcomes in patients undergoing revision hip
surgeries. Revision surgeries for failure of total
hip arthroplasty can cost the patient relevant time,
money, and risks not to mention the emotional
stress that surgical procedures can induce even
after the recovery period.
Total hip arthroplasty surgery performed
in a patient population with multiple co-morbidities
must be approached very carefully and extra effort
must be made to reduce infection, as additional
surgeries may not be possible in chronically ill
patients. Moreover, it has been shown that patients
with previous history of hip surgery undergoing
additional hip surgeries are more likely to develop
infections.
Therefore, intra-wound Vancomycin
application may be used to decrease infection rates
in revision surgeries without causing any adverse
complications as identified in this study.
Some of the limitations of this study
include our Short term follow-up of patients, small
sample size with our revision surgeries.
In conclusion, intra-wound application of
Vancomycin powder is a very promising technique
that will certainly be used more frequently to
decrease the risk of infection in hip procedures
and up until now, little studies have been done to
assess this relationship.
The results of this study will enable
surgeons to confidently use intra-wound
Vancomycin for infection prophylaxis. We
encourage more, larger sample size studies to be
performed that not only look into this association,
DISCUSSION
Reasons for higher rates of infection
include longer operative time, prolonged retraction,
and of course the use of foreign biomaterials9. The
techniques that have been developed with aim at
reducing the rate of infection following surgical
procedures include generous irritation ,
debridement and extra effort at shorter operating
times. Recently, a study by O’Neill showed that
the application of intra-wound Vancomycin
significantly reduces the risk of infection without
any acute or long-term complications. (9) O’Neill
et al reviewed 110 patients with traumatic spinal
injuries undergoing instrumented spinal fusion
procedures. Of the patients, 54received standard
systemic prophylaxis, while 56 patients received
standard systemic prophylaxis in addition to
Vancomycin powder application in the surgical
wound. The findings showed a significant decrease
in the number of infections in the group treated
with Vancomycin compared to the other group.
This finding is very promising in decreasing the
risk of postoperative surgical site infection and we
anticipate that the use of intra-wound Vancomycin
application will continue to increase. Previously,
little studies were done to assess if intra-wound
Vancomycin application will have any effects on
reducing infection after total hip arthroplasty. Our
study reveals that intra-wound Vancomycin
application has significant effects on reducing
surgical site infections and these findings are
extremely valuable in the advancement of hip
surgery. A study by Chen et al evaluated outcomes
of treating infected tibial nonunion with
Vancomycin impregnated cancellous bone
grafting.(10) They followed-up 18 patients with
infected tibial nonunion treated with adequate
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but also the relationship between other
prophylactic measures and how they impact
postoperative surgical site infection.
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